0 results available. Select is focused ,type to refine list, press Down to open the menu,
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with elec...
The following section summarizes insights on Zynex Inc's Unadjusted EBITDA:
We've identified the following companies as similar to Zynex Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Unadjusted EBITDA in the financials category include:
Unadjusted income before interest, taxes, depreciation and amortization.
Unadjusted EBITDA for Zynex is calculated as follows:
Earnings Before Taxes [ 3.627 M ]
(+) Net Interest Expenses [ 2.382 M ]
(+) Non Operating Expenses [ zero ]
(+) Depreciation and Amortization [ 4.782 M ]
(=) Unadjusted EBITDA [ 10.791 M ]
Unadjusted EBITDA is defined as Earnings before Interest, Taxes, Depreciation and Amortization. This metric does not adjust for unusual items.
It is a commonly used metric in valuation as a proxy for operating profitability. EBITDA gives us a clearer picture of profitability when comparing companies with different capital structures. So why is it useful to use EBITDA and ignore interest, taxes, depreciation, and amortization when comparing the performance of different companies?
Two companies that are otherwise similar may have different levels of debt. The company with higher debt will likely have higher interest expense and lower Net Income. Since EBITDA ignores interest expense, it is not directly affected by management’s financing decisions.
The amount of a tax a company pays each year is determined by a wide range of factors that does not always reflect the profitability of the company since the taxes a company is subject to reflects factors like political jurisdictions, past loss carryforwards, research and development tax credits, and depreciation on capital assets to name a few.
Two companies that are otherwise similar may purchase capital assets (machines, vehicles, buildings, etc.) at different times which can impact depreciation. Ignoring depreciation and amortization allows us to normalize income for these differences.
Unadjusted EBITDA is most useful in ratios to benchmark profitability, growth, credit risk, and relative valution. Popular Unadjusted EBITDA benchmark metrics include unadjusted ebitda margin, ebitda minus capex margin, unadjusted ebitda growth, and ev / ebitda.
The chart above depicts the distribution of unadjusted ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,525 companies were considered in this analysis, and 2,428 had meaningful values. The average unadjusted ebitda of companies in the sector is 45.832 M with a standard deviation of 293.4 M.
Zynex Inc's Unadjusted EBITDA of 10.791 M ranks in the 79.1% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,530 |
Included Constituents | 2,428 |
Min | -304.2 M |
Max | 2.731 B |
Median | -2.338 M |
Mean | 45.832 M |
Standard Deviation | 293.4 M |
You can find companies with similar unadjusted ebitda using this stock screener.